Literature DB >> 2317812

Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.

N E Davidson1, P A Egner, T W Kensler.   

Abstract

The substituted 1,2-dithiole-3-thione oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione] protects against the acute and chronic toxicities of many xenobiotics, including aflatoxin B1, in rodents. These protective effects are mediated, in part, through elevation of glutathione S-transferase (GST) activities. Because studies by Coles et al. [Carcinogenesis (Lond.), 6: 693-697, 1985] suggested that the detoxication of aflatoxin through conjugation with glutathione is principally catalyzed by GST homodimer YaYa, we have investigated the regulation of the gene coding for the Ya subunit in the liver of F344 rats following dietary administration of oltipraz. Overall GST activity, as measured by conjugation with 1,2-dichloro-4-nitrobenzene or 1-chloro-2,4-dinitrobenzene, as well as the levels of GST Ya protein, was elevated 1.5-fold by 24 h and maximally (2.7- to 3.5-fold) and persistently after 5 days on a purified diet supplemented with 0.075% oltipraz. Steady state mRNA levels for GST subunit Ya, as quantified by slot blot analysis using rat liver GST complementary DNA clone pGTB38, were also elevated by 24 h, with a maximal elevation of 3-fold observed at 3 days. However, mRNA levels decreased thereafter, despite continued feeding of oltipraz. Northern blot analyses demonstrated that oltipraz did not alter the size of GST mRNA. Transcriptional activity of the GST Ya gene, as determined by nuclear run-off analysis, was increased 2-fold after 24-h feeding of oltipraz, was maximally induced 2.4-fold at 3 days, and returned to near control levels at 7 days, despite sustained feeding of oltipraz. Modulation of GST activity by oltipraz was not accompanied by changes in the methylation pattern at internal sites of the GST Ya gene. These results show that the initial induction of hepatic GST activity during oltipraz exposure correlates with changes in steady state levels of GST mRNA and rates of GST gene transcription; however, the continued elevation of GST enzymatic activities and GST Ya protein levels in the face of declining GST Ya mRNA levels and transcription rates suggests that additional mechanisms may be involved in regulating GST Ya expression by oltipraz.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317812

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis.

Authors:  W W Johnson; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Impact of cephaloridine on glutathione and related enzymes: comparison of in vivo and in vitro rat models.

Authors:  F Moritz; S Marouillat; C Monteil; A Baudelot; J P Fillastre; G Bonmarchand; J P Morin
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

Authors:  P J O'Dwyer; C E Szarka; K S Yao; T C Halbherr; G R Pfeiffer; F Green; J M Gallo; J Brennan; H Frucht; E B Goosenberg; T C Hamilton; S Litwin; A M Balshem; P F Engstrom; M L Clapper
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

Review 4.  Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.

Authors:  Xiang-Lin Tan; Simon D Spivack
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

5.  Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.

Authors:  Lisa Becks; Misty Prince; Hannah Burson; Christopher Christophe; Mason Broadway; Ken Itoh; Masayuki Yamamoto; Michael Mathis; Elysse Orchard; Runhua Shi; Jerry McLarty; Kevin Pruitt; Songlin Zhang; Heather E Kleiner-Hancock
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

6.  The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Authors:  Matthew D Merrell; Jonathan P Jackson; Lisa M Augustine; Craig D Fisher; Angela L Slitt; Jonathan M Maher; Wendong Huang; David D Moore; Youcai Zhang; Curtis D Klaassen; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

7.  Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.

Authors:  N V Dimitrov; J L Bennett; J McMillan; M Perloff; C M Leece; W Malone
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

8.  Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers.

Authors:  Tamara R Knight; Supratim Choudhuri; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

Review 9.  Perspectives in cancer chemoprevention.

Authors:  G D Stoner; M A Morse; G J Kelloff
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 10.  Chemoprevention by inducers of carcinogen detoxication enzymes.

Authors:  T W Kensler
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.